Johnson & Johnson halts late-stage E.coli vaccine trial

Johnson & Johnson (JNJ) Plans $1 Billion Sale of ‘Cerenovus’ Stroke Unit
Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
Sanofi and J&J halted a phase 3 E. coli vaccine trial due to insufficient efficacy. Sanofi's Q4 2024 IFRS EPS dropped by ...
Johnson & Johnson reports progress on nipocalimab
HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...
'The evidence is overwhelming': NZ class action against Johnson and Johnson follows similar suits worldwide
A class action lawsuit launched in Auckland today questioning Johnson and Johnson cold and flu products follows similar suits ...
Jimmie Johnson scuffled in his first 2 years as NASCAR team owner. Can he make Legacy a winner?
The vision of his true NASCAR future crystalized for Jimmie Johnson at last year’s season finale. He climbed into his Toyota ...
Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times
Johnson & Johnson (NYSE:JNJ), the New Jersey-based healthcare company, is planning to sell its stroke care business, ...
Johnson & Johnson (JNJ): Jim Cramer on “The Greatest Health Care Stock of All Time”
We recently published a list of 17 Best Stocks for Kids According to Jim Cramer. In this article, we are going to take a look ...